BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19736919)

  • 1. Direct profiling of cancer biomarkers in tumor tissue using a multiplexed nanostructured microelectrode integrated circuit.
    Fang Z; Soleymani L; Pampalakis G; Yoshimoto M; Squire JA; Sargent EH; Kelley SO
    ACS Nano; 2009 Oct; 3(10):3207-13. PubMed ID: 19736919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive electrochemical biomolecular detection using nanostructured microelectrodes.
    Sage AT; Besant JD; Lam B; Sargent EH; Kelley SO
    Acc Chem Res; 2014 Aug; 47(8):2417-25. PubMed ID: 24961296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens.
    Li HR; Wang-Rodriguez J; Nair TM; Yeakley JM; Kwon YS; Bibikova M; Zheng C; Zhou L; Zhang K; Downs T; Fu XD; Fan JB
    Cancer Res; 2006 Apr; 66(8):4079-88. PubMed ID: 16618727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chip-based nanostructured sensors enable accurate identification and classification of circulating tumor cells in prostate cancer patient blood samples.
    Ivanov I; Stojcic J; Stanimirovic A; Sargent E; Nam RK; Kelley SO
    Anal Chem; 2013 Jan; 85(1):398-403. PubMed ID: 23167816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-free electronic detection of DNA-hybridization on nanogapped gold particle film.
    Shiigi H; Tokonami S; Yakabe H; Nagaoka T
    J Am Chem Soc; 2005 Mar; 127(10):3280-1. PubMed ID: 15755136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated methods for multiplexed pathogen detection.
    Straub TM; Dockendorff BP; Quiñonez-Díaz MD; Valdez CO; Shutthanandan JI; Tarasevich BJ; Grate JW; Bruckner-Lea CJ
    J Microbiol Methods; 2005 Sep; 62(3):303-16. PubMed ID: 15979746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs accurately identify cancer tissue origin.
    Rosenfeld N; Aharonov R; Meiri E; Rosenwald S; Spector Y; Zepeniuk M; Benjamin H; Shabes N; Tabak S; Levy A; Lebanony D; Goren Y; Silberschein E; Targan N; Ben-Ari A; Gilad S; Sion-Vardy N; Tobar A; Feinmesser M; Kharenko O; Nativ O; Nass D; Perelman M; Yosepovich A; Shalmon B; Polak-Charcon S; Fridman E; Avniel A; Bentwich I; Bentwich Z; Cohen D; Chajut A; Barshack I
    Nat Biotechnol; 2008 Apr; 26(4):462-9. PubMed ID: 18362881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for cervical cancer-related genes and their bioinformatics analysis].
    Chen SZ; Ma WL; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):585-8. PubMed ID: 18495597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential methylation hybridization: profiling DNA methylation with a high-density CpG island microarray.
    Yan PS; Potter D; Deatherage DE; Huang TH; Lin S
    Methods Mol Biol; 2009; 507():89-106. PubMed ID: 18987809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of breast cancer using genetic algorithms and tissue microarrays.
    Dolled-Filhart M; Rydén L; Cregger M; Jirström K; Harigopal M; Camp RL; Rimm DL
    Clin Cancer Res; 2006 Nov; 12(21):6459-68. PubMed ID: 17085660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opportunities and chances for tissue chip microarrays in head and neck surgery. A novel technique for the rapid evaluation of potentially novel biomarkers].
    Hofele C; Joos S; Flechtenmacher C; Bosch FX; Lichter P; Mühling J; Freier K
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):394-401. PubMed ID: 12447651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common cancer biomarkers.
    Basil CF; Zhao Y; Zavaglia K; Jin P; Panelli MC; Voiculescu S; Mandruzzato S; Lee HM; Seliger B; Freedman RS; Taylor PR; Hu N; Zanovello P; Marincola FM; Wang E
    Cancer Res; 2006 Mar; 66(6):2953-61. PubMed ID: 16540643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
    Malinowski DP
    Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.